Both in Biotechnology
BioCryst Pharmaceuticals vs Replimune Group
Over the past year BCRX returned +24.9% and REPL returned +121.9%; their daily moves had a correlation of 0.06.
BCRX +24.9% REPL +121.9%Growth of $1, one year, split-adjusted
| Metric | BCRX | REPL |
|---|---|---|
| Price | $8.57 | $20.65 |
| Market cap | $2.19B | $1.96B |
| Today | +3.94% | +5.95% |
| 1 month | +5.8% | +57.0% |
| 6 months | −5.1% | +619.5% |
| Year to date | +9.9% | +112.4% |
| 1 year | +17.1% | — |
| Revenue growth (YoY) | +33.6% | — |
| Gross margin | 98.2% | — |
| Net margin | 35.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | — |
| Net cash | -$471.6M | $183.7M |
| Dividend yield | — | — |
| Volatility (60d) | 44.9% | 77.7% |
| Short % of float | 10.9% | 29.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).